Investigation of the Effects of Physical Activity in Women at Risk of Osteoporosis

October 10, 2023 updated by: Fatma Nur Alçın, Pamukkale University

Investigation of the Effects of Physical Activity on Physical Fitness Parameters, Functional Fitness Age and Quality of Life in Women at Risk of Osteoporosis

The goal of this clinical trial is to investigate the effects of the increase in the physical activity level of women at risk for osteoporosis in the post-menopausal period on the physical fitness, functional fitness age and quality of life. The main question it aims to answer is:

• Does the increase in the level of physical activity positively affect the physical fitness parameters (strength, endurance, balance, agility and flexibility), functional fitness ages and quality of life of post-menopausal women with moderate to high osteoporosis risk?

Participants in the intervention group were given the Otago Exercise Program, which will last 3 days a week and an average of 30 minutes per day for 12 weeks. The exercises were done one-by-one with a physiotherapist. No program were applied to the participants in the control group, and they were asked to continue their daily living activities in the same way.

Researchers will compare two groups to see if there is a difference in effects of Otogo Exercise Program on physical fitness, functional fitness age, and quality of life.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The osteoporosis risks of the participants were calculated according to the Osteoporosis Self-Assessment Tool for Women (OST). Women have medium and high risk were included in the study.

Otago Exercise Program includes strengthening exercises consisting of knee extension, knee flexion, hip abduction, ankle dorsi flexion, and 12 balance exercises consisting of plantar flexion and squatting, walking backward, walking and rolling back, sideways walking, tandem stance, tandem gait, standing on one leg, heels walking on toes, walking on tiptoe, sitting and standing, climbing and descending stairs, and backward tandem walking.

• In addition, moderate-intensity walking exercise for 30 minutes a day, 2 days a week, was recommended to the patients in experimental group.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Burdur
      • Gölhisar, Burdur, Turkey, 15400
        • Burdur Mehmet Akif Ersoy University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being at medium-high risk as a result of the Osteoporosis Self-Assessment Tool for Women (OST)
  • Being 54 years old and over
  • Being in the post-menopausal period

Exclusion Criteria:

  • Having a broken history
  • Having a history of surgery in the last 1 year
  • Having a cognitive or physical condition that will prevent them from exercising
  • Exercising regularly for more than 30 minutes a day, at least 3 days a week

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Otago Exercise Program
They participated the Otago Exercise Program, which last 3 days a week and an average of 30 minutes per day for 12 weeks in total. In addition, they did moderate-intensity walking exercise for 30 minutes a day, 2 days a week.
Doing Otago Exercise Program, which lasting 3 days a week and an average of 30 minutes per day under the supervision of a physiotherapist. Also doing walking exercise for 30 minutes a day, 2 days a week for total of 12 weeks.
No Intervention: Control Group
No program were applied to the participants in the control group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lower Extremity Strength
Time Frame: The first measurement was made just before the start of the treatment, and the second measurement was made just after the end of the treatment.
Lower extremity strength will be evaluated with the 30-second sit-stand test included in the ''Senior Fitness Test'', which is a physical fitness assessment tool.
The first measurement was made just before the start of the treatment, and the second measurement was made just after the end of the treatment.
Upper Extremity Strength
Time Frame: The first measurement was made just before the start of the treatment, and the second measurement was made just after the end of the treatment.
Upper extremity strength will be evaluated with the 30-second elbow bend test included in the ''Senior Fitness Test'', which is a physical fitness evaluation tool.
The first measurement was made just before the start of the treatment, and the second measurement was made just after the end of the treatment.
Aerobic Endurance
Time Frame: The first measurement was made just before the start of the treatment, and the second measurement was made just after the end of the treatment.
Aerobic endurance will be evaluated with the 2-minute walking test included in the ''Senior Fitness Test'', which is a physical fitness evaluation tool.
The first measurement was made just before the start of the treatment, and the second measurement was made just after the end of the treatment.
Upper Extremity Flexibility
Time Frame: The first measurement was made just before the start of the treatment, and the second measurement was made just after the end of the treatment.
Upper extremity flexibility will be evaluated with the sit-reach test and back scratching test included in the ''Senior Fitness Test'', which is a physical fitness evaluation tool.
The first measurement was made just before the start of the treatment, and the second measurement was made just after the end of the treatment.
Agility
Time Frame: The first measurement was made just before the start of the treatment, and the second measurement was made just after the end of the treatment.
Agility will be evaluated with the stand-up and walk test included in the ''Senior Fitness Test'', which is a physical fitness evaluation tool.
The first measurement was made just before the start of the treatment, and the second measurement was made just after the end of the treatment.
Quality of Life of Individual
Time Frame: The first measurement was made just before the start of the treatment, and the second measurement was made just after the end of the treatment.
Quality of Life was tested with the ''Quality of Life for Osteoporosis Questionnaire''. The scale consists of 41 questions. There are 5 subscales: pain (5 items), physical function (17 items), social activity (7 items), general health assessment (3 items) and mental function (9 items). For each subgroup and total result in the scale, 0 points indicate the best health status, while higher scores indicate poor quality of life.
The first measurement was made just before the start of the treatment, and the second measurement was made just after the end of the treatment.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dynamic Balance
Time Frame: The first measurement was made just before the start of the treatment, and the second measurement was made just after the end of the treatment.
In addition to evaluating agility with the standing and walking test included in the "Senior Fitness Test", which is a physical condition evaluation tool, dynamic balance will also be evaluated since this test is an indicator of dynamic balance.
The first measurement was made just before the start of the treatment, and the second measurement was made just after the end of the treatment.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical Activity Level
Time Frame: The first measurement was made just before the start of the treatment, and the second measurement was made just after the end of the treatment.
The physical activity levels of the participants were evaluated with the Global Physical Activity Questionnaire. This survey, consisting of a total of 16 questions, evaluates physical activity participation in 3 different areas. These areas; work-related, transfers (walking, cycling) and leisure activities. Calculation of the total score includes the sum of the duration (minutes) and frequency (days) of walking, moderate activity and vigorous activity. The energy required for activities is calculated with the MET-minute score. An increase in this score indicates that the daily and weekly physical activity level increases.
The first measurement was made just before the start of the treatment, and the second measurement was made just after the end of the treatment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Nilüfer Çetişli Korkmaz, Prof., Pamukkale University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2022

Primary Completion (Actual)

February 15, 2023

Study Completion (Actual)

February 15, 2023

Study Registration Dates

First Submitted

August 25, 2023

First Submitted That Met QC Criteria

October 10, 2023

First Posted (Actual)

October 13, 2023

Study Record Updates

Last Update Posted (Actual)

October 13, 2023

Last Update Submitted That Met QC Criteria

October 10, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoporosis Risk

Clinical Trials on Exercise

Subscribe